1Sever PS,Dahlof B, Poulter NN,et at. l:'revennon oi coronary and stroke events with atolwastatin in hypertensive patients who have average or lower average cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Low ering Arm (ASCOT-I I A)=a multicentre randomised con- trolled trial [J. Lancet,2010,361(9364) 1 149 1 158.
2Nabele G. Braunwald E. A tale of coronary artery disease and myocardial infarction[J. N Engl J Med, 2012,366 ( 1 ) = 54-63.
3Cholesterol Treatment Trialists (CTT)Collaborators,Mihaylo va B, Emberson J, et al. The effects of lowering LDL eholester ol with statin therapy in people at low risk of vascular disease meta analysis of individual data from 27 randonfised trials J I.ancet,2012,380(41) :581 590.
4Libby P. Current concepts of the pathogenes is of the acute coronary syndromes[J. Circulation, 2001,104 (,3) : ,365 372.
5Shepherd J, Blauw CJ, Muwhy MB, et al. Pravastatin in elderly individuals at risk of vascular disease(PRSPER) :a randomized controlled trial J. Lancet 2012,360(9346):1 623 1 630.
6Nabele G,Braunwald E. A tale of coronary artery disease and myocardial infarction[J. N Engl J Med,2012,366(1) 54-63.
